Healthcare Distribution Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21663

Download Sample Report download
Buy the Full ReportStarting from $3999
Published on

January 2022

Total pages

238

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3999

About the Report

About the Report

Pharmaceutical distributors are at the heart of the United States health care ecosystem. Distributors handle 92 percent Pharmaceutical distributors are at the heart of the health care ecosystem. Distributors handle major chunk of pharmaceutical sales and add efficiency and order to a supply chain that connects highly fragmented markets, i.e., manufacturers and points of dispensation.
Distributors do much more than serve as the intermediary that ships products from manufacturers to pharmacies and providers. Distributors purchase and take legal ownership of pharmaceuticals and manage both inventory and credit risk; this allows manufacturers to focus on their core competencies of pharmaceutical drug development and manufacturing. Distributors amplify value in the health care ecosystem by delivering aggregation efficiencies and economies of scale that reduce capital and operating expenses for the broader pharmaceutical value chain.
Distributors play a critical role in supporting patient safety, enabling the right product to reach the right patient in a timely and transparent manner, including processing over 200 recall events per year. Emerging and converging market trends are impacting and reshaping distributors' traditional role of health care intermediary. These trends are providing both opportunities and challenges; in response, distributors are evolving and adapting to ensure that their services provide added value today and in the future.
Based on Type, the Healthcare Distribution Market is segmented into Pharmaceutical Product Distribution Services, Biopharmaceutical Product Distribution Services, and Medical Device Distribution Services. Amongst Type, the Pharmaceutical Product Distribution Services segment of the market was valued at USD XX billion in 2020 and is likely to reach USD XX billion by 2027 growing at a CAGR of XX% from 2021-2027.
Based on End-User, the Healthcare Distribution Market is segmented into Retail Pharmacies, Hospital Pharmacies and Others. Retail Pharmacies segment accounted for a market valuation of USD XX billion in 2020 and is expected to reach USD XX billion by the year 2027, at a CAGR of XX% over the analyzed period.
For a better understanding of the market adoption of Healthcare Distribution Industry, the market is analyzed based on its presence in the regions such as North America (US, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), Rest of World. North America will dominate the Healthcare Distribution market on account of increasing chronic diseases.
Some of the major players operating in the market include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc., Owens & Minor, Inc., Morris and Dickson Co., LLC , KeySource Medical, Inc., Rochester Drug Cooperative, Inc., Henry Schein Inc., Smith Drug Company, and FFF Enterprises. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Products


Companies

McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc., Owens & Minor, Inc., Morris and Dickson Co., LLC , KeySource Medical, Inc., Rochester Drug Cooperative, Inc., Henry Schein Inc., Smith Drug Company, and FFF Enterprises

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Limitation

1.3. Stake Holders

1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Healthcare Distribution Market

2.2. Research Methodology of the Healthcare Distribution Market

2.3. Forecasting Method

2.4. Respondent Profile

2.5. Main Objective of the Healthcare Distribution Market Study

3 MARKET SYNOPSIS (INDUSTRY AT A GLANCE)

4 EXECUTIVE SUMMARY

5 HEALTHCARE DISTRIBUTION MARKET COVID-19 IMPACT

6 HEALTHCARE DISTRIBUTION MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY TYPE

7.1. Pharmaceutical Product Distribution Services

7.1.1. OTC Drugs/Vitamins

7.1.2. Generic Drugs

7.1.3. Brand-name/Innovator Drugs

7.2. Biopharmaceutical Product Distribution Services

7.2.1. Monoclonal Antibodies

7.2.2. Vaccines

7.2.3. Recombinant Proteins

7.2.4. Blood and Blood Products

7.2.5. Other Products

7.3. Medical Device Distribution Services

8 MARKET INSIGHTS BY END-USER

8.1. Retail Pharmacies

8.2. Hospital Pharmacies

8.3. Others

9 MARKET INSIGHTS BY REGION

9.1. NORTH AMERICA HEALTHCARE DISTRIBUTION

9.1.1. United States

9.1.2. Canada

9.1.3. Rest of North America

9.2. EUROPE HEALTHCARE DISTRIBUTION

9.2.1. Germany

9.2.2. United Kingdom

9.2.3. France

9.2.4. Spain

9.2.5. Italy

9.2.6. Rest of Europe

9.3. ASIA-PACIFIC HEALTHCARE DISTRIBUTION

9.3.1. China

9.3.2. Japan

9.3.3. India

9.3.4. Aurstralia

9.3.5. Rest of Asia-Pacific

9.4. REST OF THE WORLD HEALTHCARE DISTRIBUTION

10 HEALTHCARE DISTRIBUTION MARKET DYNAMICS

10.1. Drivers

10.2. Challenges

10.3. Impact Analysis

11 HEALTHCARE DISTRIBUTION MARKET OPPORTUNITIES

12 HEALTHCARE DISTRIBUTION MARKET TRENDS

13 LEGAL AND REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1. Demand Side Analysis

14.2. Supply Side Analysis

14.2.1. Top Product Launches

14.2.2. Top Business Partnerships

14.2.3. Top Business Expansions, Investments and Divestitures

14.2.4. Top Merger and Acquisitions

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

16.1. Competitive Landscape

16.1.1. Company Shares, By Revenue

17 COMPANY PROFILED

17.1. McKesson Corporation

17.2. AmerisourceBergen Corporation

17.3. Cardinal Health, Inc.

17.4. Owens & Minor, Inc.

17.5. Morris and Dickson Co., LLC

17.6. KeySource Medical, Inc.

17.7. Rochester Drug Cooperative, Inc.

17.8. Henry Schein Inc.

17.9. Smith Drug Company

17.10. FFF Enterprises

18 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022